Does Hepatitis B Vaccination Protection Continue after 15 Years?. Ann Intern Med. 2005;142:I-34. doi: 10.7326/0003-4819-142-5-200503010-00003
Download citation file:
Published: Ann Intern Med. 2005;142(5):I-34.
Hepatitis B virus causes inflammation of the liver. The virus spreads through contact with infected body fluids, such as through sexual intercourse, open cuts, or scratches, or from mother to baby at birth. Most people do not realize that they have been infected until chronic inflammation causes complications, such as liver scarring or cancer. A hepatitis B vaccine can boost the body's immune response to the virus and help protect against infection. The vaccine is recommended for people at high risk for infection. Some research shows that the vaccine protects against infection for up to 10 years. It is not known whether the protection lasts longer than 10 years.
To see whether the hepatitis B vaccine protects against infection for up to 15 years.
841 Alaska Natives vaccinated with the hepatitis B vaccine beginning in 1981. Hepatitis B virus infection is common in Alaska Native communities, so members of those communities are especially likely to benefit from vaccination.
The researchers took blood from participants and measured hepatitis B antibodies and hepatitis B virus DNA 15 years after vaccination. They used the results to see whether the vaccine protected participants from infection and to see whether any participants developed a new infection.
The researchers found protective antibodies in 84% of the participants 15 years after vaccination. Protection from infection was more likely in men, people who had a good initial response to the vaccine, and people vaccinated when they were 5 years of age or older. Three participants became newly infected with hepatitis B virus 10 to 15 years after vaccination.
The findings may be incomplete because about half of the vaccinated participants were not available for testing 15 years later.
The hepatitis B vaccine protected most participants from infection and all participants from complications of infection for at least 15 years. People younger than age 5 at the time of vaccination may be less well protected and might benefit from booster doses of vaccine.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Gastroenterology/Hepatology, Infectious Disease, Viral Hepatitis, Vaccines/Immunization, Prevention/Screening.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only